Stocks to Watch, March 18: Tata Steel, PFC, Kirloskar Ind, VBL, Urban Co, Strides Pharma, Maruti, Adani Enterprises, Swan Defence

Its board of directors also fixed Monday, March 23, 2026, as the record date for the purpose of ascertaining the eligibility of shareholders for payment of the fourth interim dividend for FY26, a regulatory filing stated.

The date of payment of the aforesaid interim dividend shall be on or before April 16, 2026, it added.

The company added that its management has been monitoring the current crisis in the supply chain and exploring alternative sources of supply or the use of other resources to minimise the impact of disruption.

The Beverage Company Proprietary Ltd (Bevco) "has executed an agreement dated March 17, 2026, for the acquisition of a 100 per cent equity stake of Crickley Dairy Proprietary Ltd, which is incorporated in South Africa", said a regulatory filing by Varun Beverages Ltd (VBL).

The board also cleared the acquisition of a stake in Medica TS Hospital Private Limited (Medica TS Hospital) from Manipal Hospitals Eastern India Private Limited for Rs 1.49 crore, Tata Steel said in an exchange filing.

The board has approved the Scheme of Amalgamation amongst NINL, Tata Steel, and their respective shareholders.

The scheme remains subject to necessary approvals.

On the BSE, SBI MF has bought 2,24,93,959 shares at ₹109.83 apiece on the BSE.

Strides Pharma International AG (SPIAG) has entered into definitive agreements with Sandoz AG, Switzerland, and its group entities for the transaction.

The upfront consideration for the proposed transaction is $12 million, payable at closing, Strides Pharma Science said in a regulatory filing.

The transaction also provides for royalty payments to Sandoz based on a percentage of net sales of distribution products, it added.

The NPAs consist of a land parcel and building in Gurugram, Haryana, measuring about 7,800 sq m. The reserve price for the asset has been fixed at ₹250 crore, with a bid increment amount of ₹2.5 crore, as per a notice issued in newspapers.

According to the notice, the total outstanding amount stood at ₹450.85 crore as of November 31, 2024, excluding further interest and charges. The bank has taken physical possession of the property.

The e-auction will be held between 11 am and 4 pm on April 7, 2026, through an online platform.

In 2023, Carborundum Universal Ltd, part of the diversified conglomerate Murugappa Group, acquired the manufacturing lines, technology, and brand of DRONCO GmbH, Germany.

With the production, the capacity of the facility would double from 45 million to over 90 million wheels per annum, a company statement said on Tuesday.

"The plant was established at an outlay of ₹83 crore and at peak capacity utilisation is expected to generate a turnover of ₹160 crore," it said.

"The company has received a Draft Assessment Order for FY 2022 – 23 wherein certain additions / disallowances amounting to ₹57,864 million with respect to returned income have been proposed," the carmaker said in a BSE filing.

MSI will file its objections before the dispute resolution panel, it stated.

When contacted over the issue, MSIL Senior Executive Officer (Corporate Affairs) Rahul Bharti said: "The draft income tax assessment order about which the company has intimated the stock exchanges is of a routine nature. Such orders arise from time to time, largely on account of interpretation issues."

Besides, Maruti plans to drive in seven new SUVs in the next five to six years in order to enhance its share in the fast-growing segment, its managing director & CEO, Hisashi Takeuchi, said on Tuesday.

In a regulatory filing, Jaiprakash Associates Ltd (JAL) stated that the NCLT, Allahabad bench, has "orally pronounced an order on March 17, 2026" approving the resolution plan submitted by Adani Enterprises Ltd.

In November last year, a Committee of Creditors (CoC) approved the resolution plan by business tycoon Gautam Adani to acquire JAL.

Adani Enterprises won the approval of the creditors of JAL for its ₹14,535 crore acquisition proposal for the bankrupt infrastructure group. It outbid Vedanta and Dalmia Bharat to win the bid for JAL.

Subsequently, the US FDA has now determined the inspection classification status of this unit as ‘Official Action Indicated’ (OAI).

At this point in time, Aurobindo Pharma said it doesn’t foresee any impact on the business.